Alun A. Harcombe, MD, MRCP

Early and Late Reactions Following the Use of Iopamidol 340, Iomeprol 350 and Iodixanol 320 in Cardiac Catheterization

08/01/2008

Andrew G.C. Sutton , MA, MD, MRCP;

P. Finn ;

P.G. Campbell ;

D.G.A. Price ;

J.A. Hall ;

M.J. Stewart ;

A. Davies ;

N.J. Linker ;

Alun A. Harcombe , MD, MRCP;

Mark A. de Belder , MA, MD, FRCP;

The choice of contrast agent used in diagnostic cardiac catheterization might be considered relatively unimportant compared to decisions on arterial access, choice of catheters and potential technical pitfalls. However, the choice of contrast...

The choice of contrast agent...

08/01/2008

Journal of Invasive Cardiology

A Prospective, Randomized Trial to Determine the Early and
Late Reactions After the Use of Iopamidol 340 (Niopam‚Ñ¢)
and Iobitri

08/01/2008

James A. Hall , MA, MD, FRCP;

David O. Williams , MD, PhD;

Nicholas J. Linker , MD, FRCP, FESC;

Michael J. Stewart , MD, FRCP;

Adrian Davies , BSc, MB, FRCP;

Alun A. Harcombe , MD, MRCP;

Mark A. de Belder , MA, MD, FRCP;

Kunadian Vijayalakshmi , MBBS, MRCP;

Intravascular contrast is a prerequisite for modern invasive cardiology. The contrast agents used for various procedures have become increasingly safe in recent years. Compared to ionic agents, the modern non-ionic contrast agents are fairly...

Intravascular contrast is a...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Early and Late Reactions Following the Use of Iopamidol 340, Iomeprol 350 and Iodixanol 320 in Cardiac Catheterization

03/27/2012

J.A. Hall ;

M.J. Stewart ;

A. Davies ;

N.J. Linker ;

Alun A. Harcombe , MD, MRCP;

Mark A. de Belder , MA, MD, FRCP;

Andrew G.C. Sutton , MA, MD, MRCP;

P. Finn ;

P.G. Campbell ;

D.G.A. Price ;

ABSTRACT: Goal. To investigate the incidence of early (< 24 hours) and late (> 24 hours to 7 days) reactions to 3 contrast agents commonly used in cardiac catheterization. Methods and Results. A total of 2,108 patients undergoing...

ABSTRACT: Goal. To investigate...

03/27/2012

Journal of Invasive Cardiology

Original Contribution

One-Year Clinical Outcomes of the Hybrid CTO Revascularization Strategy After Hospital Discharge: A Subanalysis of the Multicenter RECHARGE Registry

11/15/2017

Alexander J. Chase , MBBCh, PhD, MBBS, MD;

Erwan Bressollette , MD;

Dave Smith , BM, MD;

William H.T. Smith , MB, MA, MRCP, PhD, FRCP;

John Irving , MD;

Simon J. Walsh , MD;

Joseph "Jo" Dens , MD, PhD;

Andrew Ladwiniec , MD;

Margaret B. McEntegart , MD, PhD, BSc(Hons), MBChB;

Alexandre Avran , MD, PhD;

Paul Knaapen , MD, PhD;

Benjamin Faurie , MD, PhD;

Pierfrancesco Agostoni , MD, PhD;

Alun A. Harcombe , MD, MRCP;

James C. Spratt , MD, FRCP, BSc, MBChB;

Colm G. Hanratty , MD;

Peter Kayaert , PhD, MD;

Joren Maeremans , MSc;

The hybrid algorithm and contemporary wiring and dissection re-entry techniques can potentially improve long-term outcomes after CTO-PCI. This study assessed the long-term clinical outcomes of the hybrid CTO practice, when applied by...

The hybrid algorithm and...

11/15/2017

Journal of Invasive Cardiology